GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial

Mostrar otras versiones (1)

OBJECTIVES: Because of the limitations of randomized controlled trials (RCTs) and observational studies, a prospective, randomized, open-label, blinded endpoint (PROBE) study may be an appropriate alternative, as the design allows the assessment of clinical outcomes in clinical practice settings. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Cryer, Byron, Li, Chunming, Simon, Lee S, Singh, Gurkirpal, Stillman, Martin J, Berger, Manuela F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Stomach
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590424/
https://www.ncbi.nlm.nih.gov/pubmed/23399552
http://dx.doi.org/10.1038/ajg.2012.467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590424/
https://www.ncbi.nlm.nih.gov/pubmed/23399552
http://dx.doi.org/10.1038/ajg.2012.467

Ejemplares similares